Article ID Journal Published Year Pages File Type
6800689 Journal of Psychiatric Research 2015 9 Pages PDF
Abstract
Our data demonstrate for the first time that the perinatal BPA exposure induces an anxiety-like phenotype in behaviors and -related neuroendocrinology, and suggest that the changes in mGlu2/3 receptor might lie at the core of the pathological reprogramming triggered by early-life adversity. mGlu2/3 receptor may serve as a novel biomarker and potential therapeutic target for anxiety disorders associated with adverse early-life agents including perinatal BPA exposure.
Related Topics
Life Sciences Neuroscience Biological Psychiatry
Authors
, , , , , ,